Verona Pharma plc
VRNADelisted Oct 7, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001657312
Verona Pharma plc was delisted on Oct 7, 2025; its insiders filed their last Form 4 on Oct 8, 2025; 243 institutions reported holding it in 13F filings for Q3 2025, worth $8.57B in total; superinvestors Duquesne Family Office and Soros Fund Management held it.
Q3 2024 vs. Q2 2024
How the institutions holding Verona Pharma plc changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Of which not filed for Q3 2024 | Q3 2024 | Change |
|---|---|---|---|---|
| Holders | 125 | 1 | 150 | +26 |
| Shares | 66.2M | 430.4K | 67.7M | +1.92M (+2.9%) |
| Value | $957.0M | $6.22M | $1.95B | +$999.5M (+105.1%) |
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (45)
Institutions that held Verona Pharma plc at the end of Q3 2024 but not at the end of Q2 2024.
Sold out (19)
Institutions that held Verona Pharma plc at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| OrbiMed Advisors LLC | 2,861,801 | $41.4M |
| Carlyle Group Inc. | 2,457,500 | $35.5M |
| Laurion Capital Management LP | 1,050,842 | $15.2M |
| Paradigm Biocapital Advisors LP | 721,087 | $10.4M |
| Ikarian Capital, LLC | 201,116 | $2.91M |
| Adage Capital Partners GP, L.L.C. | 175,000 | $2.53M |
| Jump Financial, LLC | 168,438 | $2.44M |
| Susquehanna International Group, LLP | 117,397 | $1.70M |
| CM Management, LLC | 35,000 | $506.1K |
| State Street Corp | 33,572 | $485.5K |
| Renaissance Technologies LLC | 31,044 | $448.9K |
| Ameriprise Financial Inc | 13,159 | $190.3K |
| Nomura Holdings Inc | 10,000 | $144.6K |
| GWM Advisors LLC | 7,300 | $105.6K |
| Quarry LP | 2,000 | $28.9K |
| Redwood Wealth Management Group, LLC | 410 | $5.93K |
| National Bank of Canada | 150 | $2.31K |
| Naples Money Management LLC | 100 | $1.55K |
| Northwestern Mutual Wealth Management Co | 64 | $925 |
Not filed for Q3 2024 yet (1)
Institutions that held Verona Pharma plc at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| BlackRock Inc. | 430,429 | $6.22M |